UK NHS adds Wegovy weight loss pill to prescription formulary by mid-2027
Resolves: The NHS issues a formal update or guidance document listing Wegovy (semaglutide) weight loss pill as an approved prescription medication in the UK.
user-generated· regulatory
UK NHS adds Wegovy weight loss pill to prescription formulary by mid-…
Market overview
The NHS will formally include the Wegovy weight loss pill in its prescription formulary by June 2027, following successful private market adoption and clinical review. This will significantly expand access and reduce out-of-pocket costs for eligible patients.
regulatory prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-06-30
About this prediction
Resolution criteria
The NHS issues a formal update or guidance document listing Wegovy (semaglutide) weight loss pill as an approved prescription medication in the UK.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…